Hims & Hers Health reported Q2 2024 revenue of $315.6M, beat analyst consensus of $299.9M by $15.7M. Diluted EPS came in at $0.06, beat the $0.04 consensus by $0.02.
Trailing eight quarters through Q2 2024
Common questions about Hims & Hers Health's Q2 2024 earnings report.
Hims & Hers Health (HIMS) reported Q2 2024 earnings on August 5, 2024 after market close.
Hims & Hers Health reported revenue of $315.6M and diluted EPS of $0.06 for Q2 2024.
Revenue beat the consensus estimate of $299.9M by $15.7M. EPS beat the consensus estimate of $0.04 by $0.02.
You can read the 10-Q periodic report (0001773751-24-000248) directly on SEC EDGAR. The filing index links above go to sec.gov.